Literature DB >> 28099230

Primary Orbital Chondromyxoid Fibroma: A Rare Case.

Martin G Mullen1, Marie Somogyi, Sean P Maxwell, Vikram Prabhu, David K Yoo.   

Abstract

A 56-year-old male with history of chronic sinusitis was found to have a 3 cm left orbital lesion on CT. Subsequent MRI demonstrated a multilobulated enhancing soft tissue lesion at the superotemporal region of the left orbit. Initial biopsy was reported as a low-grade sarcoma. On further evaluation, a consensus was made that the lesion was likely a benign mixed mesenchymal type tumor but should nonetheless be surgically removed. Left lateral orbitotomy was performed which revealed a tumor originating in the lateral orbital bone with segments eroding through the wall of the orbit. Intraoperative frozen sections revealed myoepitheliod tissue with locally aggressive features and the tumor was completely removed. The final histopathologic analysis of the tissue was consistent with a chondromyxoid fibroma. Chondomyxoid fibroma is a rare entity in the orbital bones and is more commonly seen in long bones.

Entities:  

Mesh:

Year:  2017        PMID: 28099230     DOI: 10.1097/IOP.0000000000000857

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Primary Orbital Chondromyxoid Fibroma: A Cause of Monosymptomatic Periocular Pain.

Authors:  Louise Hildestad; Steffen Heegaard; Peter Bjerre Toft
Journal:  Case Rep Ophthalmol       Date:  2021-04-12

Review 2.  Chondromyxoid fibroma of the temporal bone: A rare case report.

Authors:  Tao Liu; Jing Yao; Xiaoyu Li; Xinmeng Qi; Pengyun Zhao; Zhiqiao Tan; Jie Wang; Yongxin Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

3.  Primary chondromyxoid fibroma of the orbit: An orbital mass with calcification.

Authors:  Aditi Mehta Grewal; Manpreet Singh; Vikarn Vishwajeet; Umang Thakur; Ashim Das; Pankaj Gupta
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.